Sb202190
SB202190 is a potent and selective inhibitor of p38 MAPK, a key enzyme involved in various cellular processes. It functions by blocking the phosphorylation and activation of p38 MAPK. SB202190 is commonly used in research applications to investigate the role of p38 MAPK in cellular signaling pathways.
Lab products found in correlation
18 protocols using sb202190
Establishment and Culture of Patient-Derived Organoids
Esophageal Cancer Cell Line Cultivation
Reagent Acquisition and Purification
was obtained from Aldrich Chemical Co., Inc. (Milwaukee, WI, USA) and SB202190
was purchased from MedChem Express (Monmouth Junction, NJ, USA). All other
chemicals were reagent grade and purchased from commercial sources and used
without further purification.
Anti-inflammatory Effects of Crocetin
Esophageal Cancer Cell Line Cultivation and SFE Compound Preparation
Establishing Long-term HGSC Organoid Cultures
Osteogenic Differentiation of BMSCs
Apoptosis and Autophagy Signaling Pathway
Impacts of MAPK Pathways on Pancreatic Cancer Migration
Investigating Stress-Induced Migration in Pancreatic Cancer
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!